Clonidine Patch Suppliers & Bulk Manufacturers
Available Forms: transdermal patch
Available Strengths: 0.1 mg/24 hours, 0.2 mg/24 hours, 0.3 mg/24 hours
Reference Brands: Catapres(US)
Category:
Hypertension
Clonidine patches deliver alpha-2 adrenergic agonist directly through the skin, reducing sympathetic nerve activity and lowering blood pressure. They provide steady medication levels, enhance compliance, and support long-term hypertension control. Benefits include convenient once-weekly application, consistent blood pressure reduction, and improved patient adherence.
Clonidine Patch is available in transdermal patch
and strengths such as 0.1 mg/24 hours, 0.2 mg/24 hours, 0.3 mg/24 hours.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Clonidine Patch is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Clonidine Patch can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Clonidine patches, marketed as Catapres-TTS and generic versions, are approved in the US by the FDA and in the EU via EMA for hypertension management. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and global availability of clonidine patches, facilitating blood pressure control and improving patient adherence worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing